Amanda M Legemaat1, Maria Semkovska2, Marlies Brouwer1, Gert J Geurtsen3, Huibert Burger4, Damiaan Denys1, Claudi L Bockting1,5. 1. Department of Psychiatry, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam Neuroscience & Amsterdam Public Health, Meibergdreef 9 1105 AZ, Amsterdam, The Netherlands. 2. Department of Psychology, University of Southern Denmark, Campusvej 55 DK-5230 Odense M, Denmark. 3. Department of Medical Psychology, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam Neuroscience & Amsterdam Public Health, Meibergdreef 9 1105 AZ, Amsterdam, The Netherlands. 4. Department of General Practice and Elderly Care Medicine, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1 9713 AV, Groningen, The Netherlands. 5. Centre for Urban Mental Health, University of Amsterdam, Oude Turfmarkt 147 1012 GC, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Preliminary evidence suggests beneficial effects of cognitive remediation in depression. An update of the current evidence is needed. The aim was to systematically assess the effectiveness of cognitive remediation in depression on three outcomes. METHODS: The meta-analysis was pre-registered on PROSPERO (CRD42019124316). PubMed, PsycINFO, Embase and Cochrane Library were searched on 2 February 2019 and 8 November 2020 for peer-reviewed published articles. We included randomized and non-randomized clinical trials comparing cognitive remediation to control conditions in adults with primary depression. Random-effects models were used to calculate Hedges' g, and moderators were assessed using mixed-effects subgroup analyses and meta-regression. Main outcome categories were post-treatment depressive symptomatology (DS), cognitive functioning (CF) and daily functioning (DF). RESULTS: We identified 5221 records and included 21 studies reporting on 24 comparisons, with 438 depressed patients receiving cognitive remediation and 540 patients in a control condition. We found a small effect on DS (g = 0.28, 95% CI 0.09-0.46, I2 40%), a medium effect on CF (g = 0.60, 95% CI 0.37-0.83, I2 44%) and a small effect on DF (g = 0.22, 95% CI 0.06-0.39, I2 3%). There were no significant effects at follow-up. Confounding bias analyses indicated possible overestimation of the DS and DF effects in the original studies. CONCLUSIONS: Cognitive remediation in depression improves CF in the short term. The effects on DS and DF may have been overestimated. Baseline depressive symptom severity should be considered when administering cognitive remediation.
BACKGROUND: Preliminary evidence suggests beneficial effects of cognitive remediation in depression. An update of the current evidence is needed. The aim was to systematically assess the effectiveness of cognitive remediation in depression on three outcomes. METHODS: The meta-analysis was pre-registered on PROSPERO (CRD42019124316). PubMed, PsycINFO, Embase and Cochrane Library were searched on 2 February 2019 and 8 November 2020 for peer-reviewed published articles. We included randomized and non-randomized clinical trials comparing cognitive remediation to control conditions in adults with primary depression. Random-effects models were used to calculate Hedges' g, and moderators were assessed using mixed-effects subgroup analyses and meta-regression. Main outcome categories were post-treatment depressive symptomatology (DS), cognitive functioning (CF) and daily functioning (DF). RESULTS: We identified 5221 records and included 21 studies reporting on 24 comparisons, with 438 depressedpatients receiving cognitive remediation and 540 patients in a control condition. We found a small effect on DS (g = 0.28, 95% CI 0.09-0.46, I2 40%), a medium effect on CF (g = 0.60, 95% CI 0.37-0.83, I2 44%) and a small effect on DF (g = 0.22, 95% CI 0.06-0.39, I2 3%). There were no significant effects at follow-up. Confounding bias analyses indicated possible overestimation of the DS and DF effects in the original studies. CONCLUSIONS: Cognitive remediation in depression improves CF in the short term. The effects on DS and DF may have been overestimated. Baseline depressive symptom severity should be considered when administering cognitive remediation.
Authors: Claudi Bockting; Amanda M Legemaat; Johanne G J van der Stappen; Gert J Geurtsen; Maria Semkovska; Huibert Burger; Isidoor O Bergfeld; Nicoline Lous; Damiaan A J P Denys; Marlies Brouwer Journal: BMJ Open Date: 2022-06-23 Impact factor: 3.006
Authors: Amit Lampit; Nathalie H Launder; Ruth Minkov; Alice Rollini; Christopher G Davey; Carsten Finke; Nicola T Lautenschlager; Hanna Malmberg Gavelin Journal: Syst Rev Date: 2022-01-06
Authors: Bart Meuleman; Janna N Vrijsen; Marie-Anne Vanderhasselt; Ernst H W Koster; Peter Oostelbos; Paul Naarding; Linda Bolier; Indira Tendolkar; Filip Smit; Jan Spijker; Eni S Becker Journal: BMC Psychiatry Date: 2021-11-27 Impact factor: 3.630
Authors: Katie M Douglas; Maree L Inder; Marie T Crowe; Jennifer Jordan; Dave Carlye; Cameron Lacey; Ben Beaglehole; Roger Mulder; Kate Eggleston; Katherine A Donovan; Christopher M A Frampton; Christopher R Bowie; Richard J Porter Journal: BMC Psychiatry Date: 2022-02-14 Impact factor: 3.630